25 XP   0   0   10

Recce Ltd
Buy, Hold or Sell?

Let's analyse Recce together

PenkeI guess you are interested in Recce Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Recce Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Recce Ltd

I send you an email if I find something interesting about Recce Ltd.

Quick analysis of Recce (30 sec.)










What can you expect buying and holding a share of Recce? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$-0.01
Expected worth in 1 year
A$-0.26
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.25
Return On Investment
-52.3%

For what price can you sell your share?

Current Price per Share
A$0.48
Expected price per share
A$0.435 - A$0.505
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Recce (5 min.)




Live pricePrice per Share (EOD)

A$0.48

Intrinsic Value Per Share

A$-0.90 - A$-0.76

Total Value Per Share

A$-0.91 - A$-0.77

2. Growth of Recce (5 min.)




Is Recce growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.6m$6.5m-$8.2m-488.6%

How much money is Recce making?

Current yearPrevious yearGrowGrow %
Making money-$8.5m-$7.1m-$1.3m-16.0%
Net Profit Margin-295.1%-346.0%--

How much money comes from the company's main activities?

3. Financial Health of Recce (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#923 / 1049

Most Revenue
#411 / 1049

Most Profit
#564 / 1049

Most Efficient
#714 / 1049
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Recce? (5 min.)

Welcome investor! Recce's management wants to use your money to grow the business. In return you get a share of Recce.

What can you expect buying and holding a share of Recce?

First you should know what it really means to hold a share of Recce. And how you can make/lose money.

Speculation

The Price per Share of Recce is A$0.475. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Recce.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Recce, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$-0.01. Based on the TTM, the Book Value Change Per Share is A$-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Recce.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.04-8.8%-0.04-8.8%-0.04-7.4%-0.03-6.0%-0.02-3.7%
Usd Book Value Change Per Share-0.04-8.6%-0.04-8.6%-0.03-7.1%0.00-0.4%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.011.2%0.000.5%0.000.2%
Usd Total Gains Per Share-0.04-8.6%-0.04-8.6%-0.03-5.9%0.000.0%0.000.1%
Usd Price Per Share0.41-0.41-0.58-0.44-0.26-
Price to Earnings Ratio-9.74--9.74--16.50--17.51--13.50-
Price-to-Total Gains Ratio-10.06--10.06--20.78--5.89-35.40-
Price to Book Ratio-49.18--49.18-18.02--14.18-7.01-
Price-to-Total Gains Ratio-10.06--10.06--20.78--5.89-35.40-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.31065
Number of shares3219
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.040.00
Usd Total Gains Per Share-0.040.00
Gains per Quarter (3219 shares)-130.740.32
Gains per Year (3219 shares)-522.951.27
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-523-53328-27-9
20-1046-105657-54-8
30-1569-157985-81-7
40-2092-2102114-109-6
50-2615-2625142-136-5
60-3138-3148171-163-4
70-3661-3671199-190-3
80-4184-4194227-217-2
90-4707-4717256-244-1
100-5229-5240284-2710

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%4.06.00.040.0%
Dividend per Share0.00.01.00.0%1.00.02.033.3%2.00.03.040.0%2.00.08.020.0%2.00.08.020.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%4.06.00.040.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Recce

About Recce Ltd

Recce Pharmaceuticals Ltd, a biotechnology company, discovers, develops, and commercializes synthetic anti"infectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer antibiotic formulated for oral use. In addition, the company engages in R327 Intravenous which provides serious/life-threatening bacterial infections, including sepsis which is in the phase 1 trial; urinary tract infections, including urosepsis; rapid infusions sepsis in the phase 2 trial; and R327 Topical offers wound infections, including infected burns; and diabetic foot ulcer infections in Phase 2 trails. Further, the company operates various pre-clinical programs, such as Mycobacterium abscessus which is in phase 1 clinical trial; bacterial sinusitis; and additional TBA. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-02-19 20:47:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Recce Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Recce earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Recce to the Biotechnology industry mean.
  • A Net Profit Margin of -295.1% means that $-2.95 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Recce Ltd:

  • The MRQ is -295.1%. The company is making a huge loss. -2
  • The TTM is -295.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-295.1%TTM-295.1%0.0%
TTM-295.1%YOY-346.0%+50.9%
TTM-295.1%5Y-458.0%+162.9%
5Y-458.0%10Y-3,438.3%+2,980.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-295.1%-172.8%-122.3%
TTM-295.1%-220.0%-75.1%
YOY-346.0%-286.5%-59.5%
5Y-458.0%-479.9%+21.9%
10Y-3,438.3%-595.0%-2,843.3%
1.1.2. Return on Assets

Shows how efficient Recce is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Recce to the Biotechnology industry mean.
  • -511.7% Return on Assets means that Recce generated $-5.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Recce Ltd:

  • The MRQ is -511.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -511.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-511.7%TTM-511.7%0.0%
TTM-511.7%YOY-87.0%-424.6%
TTM-511.7%5Y-228.3%-283.4%
5Y-228.3%10Y-181.8%-46.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-511.7%-12.4%-499.3%
TTM-511.7%-12.1%-499.6%
YOY-87.0%-11.2%-75.8%
5Y-228.3%-13.7%-214.6%
10Y-181.8%-15.1%-166.7%
1.1.3. Return on Equity

Shows how efficient Recce is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Recce to the Biotechnology industry mean.
  • 0.0% Return on Equity means Recce generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Recce Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-109.2%+109.2%
TTM-5Y-82.7%+82.7%
5Y-82.7%10Y-131.5%+48.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.8%+15.8%
TTM--15.1%+15.1%
YOY-109.2%-14.2%-95.0%
5Y-82.7%-18.5%-64.2%
10Y-131.5%-19.7%-111.8%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Recce Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Recce is operating .

  • Measures how much profit Recce makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Recce to the Biotechnology industry mean.
  • An Operating Margin of -291.2% means the company generated $-2.91  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Recce Ltd:

  • The MRQ is -291.2%. The company is operating very inefficient. -2
  • The TTM is -291.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-291.2%TTM-291.2%0.0%
TTM-291.2%YOY-345.8%+54.6%
TTM-291.2%5Y-419.1%+127.9%
5Y-419.1%10Y-3,415.7%+2,996.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-291.2%-284.4%-6.8%
TTM-291.2%-222.5%-68.7%
YOY-345.8%-285.9%-59.9%
5Y-419.1%-470.0%+50.9%
10Y-3,415.7%-599.5%-2,816.2%
1.2.2. Operating Ratio

Measures how efficient Recce is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.89 means that the operating costs are $3.89 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Recce Ltd:

  • The MRQ is 3.891. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.891. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.891TTM3.8910.000
TTM3.891YOY3.966-0.075
TTM3.8915Y5.142-1.251
5Y5.14210Y51.465-46.323
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8912.906+0.985
TTM3.8913.299+0.592
YOY3.9663.814+0.152
5Y5.1425.925-0.783
10Y51.4657.406+44.059
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Recce Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Recce is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.40 means the company has $0.40 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Recce Ltd:

  • The MRQ is 0.402. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.402. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.402TTM0.4020.000
TTM0.402YOY4.980-4.578
TTM0.4025Y5.695-5.294
5Y5.69510Y6.942-1.247
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4024.019-3.617
TTM0.4024.479-4.077
YOY4.9805.577-0.597
5Y5.6956.201-0.506
10Y6.9426.549+0.393
1.3.2. Quick Ratio

Measures if Recce is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Recce to the Biotechnology industry mean.
  • A Quick Ratio of 0.35 means the company can pay off $0.35 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Recce Ltd:

  • The MRQ is 0.350. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.350. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.350TTM0.3500.000
TTM0.350YOY4.816-4.466
TTM0.3505Y5.635-5.285
5Y5.63510Y6.860-1.225
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3503.566-3.216
TTM0.3504.108-3.758
YOY4.8165.460-0.644
5Y5.6356.107-0.472
10Y6.8606.377+0.483
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Recce Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Recce assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Recce to Biotechnology industry mean.
  • A Debt to Asset Ratio of 2.01 means that Recce assets are financed with 201.3% credit (debt) and the remaining percentage (100% - 201.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Recce Ltd:

  • The MRQ is 2.013. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.013. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.013TTM2.0130.000
TTM2.013YOY0.203+1.810
TTM2.0135Y0.799+1.213
5Y0.79910Y0.648+0.152
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0130.330+1.683
TTM2.0130.328+1.685
YOY0.2030.262-0.059
5Y0.7990.370+0.429
10Y0.6480.380+0.268
1.4.2. Debt to Equity Ratio

Measures if Recce is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Recce to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Recce Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.255-0.255
TTM-5Y0.143-0.143
5Y0.14310Y0.296-0.153
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.375-0.375
TTM-0.396-0.396
YOY0.2550.320-0.065
5Y0.1430.429-0.286
10Y0.2960.467-0.171
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Recce Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Recce generates.

  • Above 15 is considered overpriced but always compare Recce to the Biotechnology industry mean.
  • A PE ratio of -9.74 means the investor is paying $-9.74 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Recce Ltd:

  • The EOD is -7.399. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.735. Based on the earnings, the company is expensive. -2
  • The TTM is -9.735. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.399MRQ-9.735+2.336
MRQ-9.735TTM-9.7350.000
TTM-9.735YOY-16.502+6.767
TTM-9.7355Y-17.515+7.780
5Y-17.51510Y-13.501-4.014
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.399-2.555-4.844
MRQ-9.735-2.211-7.524
TTM-9.735-2.774-6.961
YOY-16.502-4.419-12.083
5Y-17.515-6.090-11.425
10Y-13.501-6.243-7.258
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Recce Ltd:

  • The EOD is -7.603. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.004. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.004. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.603MRQ-10.004+2.401
MRQ-10.004TTM-10.0040.000
TTM-10.004YOY-20.031+10.027
TTM-10.0045Y-115.341+105.337
5Y-115.34110Y-64.240-51.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.603-3.204-4.399
MRQ-10.004-2.831-7.173
TTM-10.004-3.510-6.494
YOY-20.031-6.014-14.017
5Y-115.341-8.190-107.151
10Y-64.240-8.624-55.616
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Recce is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -49.18 means the investor is paying $-49.18 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Recce Ltd:

  • The EOD is -37.376. Based on the equity, the company is expensive. -2
  • The MRQ is -49.179. Based on the equity, the company is expensive. -2
  • The TTM is -49.179. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-37.376MRQ-49.179+11.803
MRQ-49.179TTM-49.1790.000
TTM-49.179YOY18.019-67.198
TTM-49.1795Y-14.176-35.002
5Y-14.17610Y7.007-21.183
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-37.3762.053-39.429
MRQ-49.1791.839-51.018
TTM-49.1792.099-51.278
YOY18.0193.048+14.971
5Y-14.1763.527-17.703
10Y7.0073.828+3.179
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Recce Ltd.

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Recce Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.062-0.0620%-0.051-17%-0.003-95%-0.001-98%
Book Value Per Share---0.013-0.0130%0.049-126%0.029-143%0.019-166%
Current Ratio--0.4020.4020%4.980-92%5.695-93%6.942-94%
Debt To Asset Ratio--2.0132.0130%0.203+892%0.799+152%0.648+211%
Debt To Equity Ratio----0%0.255-100%0.143-100%0.296-100%
Dividend Per Share----0%0.008-100%0.003-100%0.002-100%
Eps---0.064-0.0640%-0.054-16%-0.044-32%-0.027-58%
Free Cash Flow Per Share---0.062-0.0620%-0.044-29%-0.033-47%-0.020-68%
Free Cash Flow To Equity Per Share---0.049-0.0490%-0.046-7%0.003-1534%0.002-2389%
Gross Profit Margin--1.0861.0860%1.0900%1.044+4%1.022+6%
Intrinsic Value_10Y_max---0.758--------
Intrinsic Value_10Y_min---0.897--------
Intrinsic Value_1Y_max---0.042--------
Intrinsic Value_1Y_min---0.060--------
Intrinsic Value_3Y_max---0.153--------
Intrinsic Value_3Y_min---0.206--------
Intrinsic Value_5Y_max---0.294--------
Intrinsic Value_5Y_min---0.382--------
Market Cap96758450.000-32%127313750.000127313750.0000%181294780.000-30%135665532.000-6%80971545.000+57%
Net Profit Margin---2.951-2.9510%-3.460+17%-4.580+55%-34.383+1065%
Operating Margin---2.912-2.9120%-3.458+19%-4.191+44%-34.157+1073%
Operating Ratio--3.8913.8910%3.966-2%5.142-24%51.465-92%
Pb Ratio-37.376+24%-49.179-49.1790%18.019-373%-14.176-71%7.007-802%
Pe Ratio-7.399+24%-9.735-9.7350%-16.502+70%-17.515+80%-13.501+39%
Price Per Share0.475-32%0.6250.6250%0.890-30%0.666-6%0.398+57%
Price To Free Cash Flow Ratio-7.603+24%-10.004-10.0040%-20.031+100%-115.341+1053%-64.240+542%
Price To Total Gains Ratio-7.649+24%-10.064-10.0640%-20.782+106%-5.893-41%35.404-128%
Quick Ratio--0.3500.3500%4.816-93%5.635-94%6.860-95%
Return On Assets---5.117-5.1170%-0.870-83%-2.283-55%-1.818-64%
Return On Equity----0%-1.0920%-0.8270%-1.3150%
Total Gains Per Share---0.062-0.0620%-0.043-31%0.000-41271%0.000-15008%
Usd Book Value---1693077.816-1693077.8160%6580128.132-126%3908731.847-143%2572855.685-166%
Usd Book Value Change Per Share---0.041-0.0410%-0.034-17%-0.002-95%-0.001-98%
Usd Book Value Per Share---0.008-0.0080%0.032-126%0.019-143%0.013-166%
Usd Dividend Per Share----0%0.006-100%0.002-100%0.001-100%
Usd Eps---0.042-0.0420%-0.035-16%-0.029-32%-0.018-58%
Usd Free Cash Flow---8322805.962-8322805.9620%-5919097.632-29%-4396422.394-47%-2656172.669-68%
Usd Free Cash Flow Per Share---0.041-0.0410%-0.029-29%-0.022-47%-0.013-68%
Usd Free Cash Flow To Equity Per Share---0.032-0.0320%-0.030-7%0.002-1534%0.001-2389%
Usd Market Cap63280026.300-32%83263192.50083263192.5000%118566786.120-30%88725257.928-6%52955390.430+57%
Usd Price Per Share0.311-32%0.4090.4090%0.582-30%0.436-6%0.260+57%
Usd Profit---8552633.988-8552633.9880%-7186605.222-16%-6194316.266-28%-3768341.068-56%
Usd Revenue--2898142.1402898142.1400%2077071.300+40%1491742.608+94%862435.032+236%
Usd Total Gains Per Share---0.041-0.0410%-0.028-31%0.000-41271%0.000-15008%
 EOD+2 -6MRQTTM+0 -0YOY+8 -275Y+8 -2710Y+10 -25

4.2. Fundamental Score

Let's check the fundamental score of Recce Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.399
Price to Book Ratio (EOD)Between0-1-37.376
Net Profit Margin (MRQ)Greater than0-2.951
Operating Margin (MRQ)Greater than0-2.912
Quick Ratio (MRQ)Greater than10.350
Current Ratio (MRQ)Greater than10.402
Debt to Asset Ratio (MRQ)Less than12.013
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-5.117
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Recce Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.470
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Total Other Income Expense Net -5711-4644-20-24,2854,282



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets2,556
Total Liabilities5,145
Total Stockholder Equity-2,589
 As reported
Total Liabilities 5,145
Total Stockholder Equity+ -2,589
Total Assets = 2,556

Assets

Total Assets2,556
Total Current Assets1,947
Long-term Assets608
Total Current Assets
Cash And Cash Equivalents 1,562
Short-term Investments 47
Net Receivables 91
Inventory 135
Other Current Assets 160
Total Current Assets  (as reported)1,947
Total Current Assets  (calculated)1,994
+/- 47
Long-term Assets
Property Plant Equipment 608
Intangible Assets 0
Long-term Assets Other 0
Long-term Assets  (as reported)608
Long-term Assets  (calculated)608
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,850
Long-term Liabilities295
Total Stockholder Equity-2,589
Total Current Liabilities
Short-term Debt 148
Accounts payable 949
Other Current Liabilities 3,901
Total Current Liabilities  (as reported)4,850
Total Current Liabilities  (calculated)4,998
+/- 148
Long-term Liabilities
Long term Debt Total 103
Other Liabilities 192
Long-term Liabilities  (as reported)295
Long-term Liabilities  (calculated)295
+/- 0
Total Stockholder Equity
Common Stock44,112
Retained Earnings -55,535
Other Stockholders Equity 8,835
Total Stockholder Equity (as reported)-2,589
Total Stockholder Equity (calculated)-2,589
+/-0
Other
Capital Stock44,112
Cash and Short Term Investments 1,562
Common Stock Shares Outstanding 173,978
Current Deferred Revenue-148
Liabilities and Stockholders Equity 2,556
Net Debt -1,311
Net Invested Capital -2,589
Net Tangible Assets -2,589
Net Working Capital -2,902
Property Plant and Equipment Gross 1,201
Short Long Term Debt Total 251



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-30
> Total Assets 
32
80
148
4,987
3,721
1,465
1,144
922
3,244
21,682
12,624
2,556
2,55612,62421,6823,2449221,1441,4653,7214,9871488032
   > Total Current Assets 
0
0
94
4,908
3,637
1,154
708
453
2,739
21,181
12,185
1,947
1,94712,18521,1812,7394537081,1543,6374,9089400
       Cash And Cash Equivalents 
1
43
94
4,892
3,591
1,090
680
403
2,682
20,873
11,582
1,562
1,56211,58220,8732,6824036801,0903,5914,89294431
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
20
47
47200000000000
       Net Receivables 
0
0
0
16
40
60
21
37
41
245
182
91
91182245413721604016000
       Other Current Assets 
0
0
0
0
6
3
8
13
16
62
420
160
1604206216138360000
   > Long-term Assets 
0
0
0
79
83
311
435
469
505
501
439
608
6084395015054694353118379000
       Property Plant Equipment 
32
37
54
79
83
311
435
469
505
501
439
608
6084395015054694353118379543732
       Intangible Assets 
0
0
0
1
1
0
0
0
0
0
0
0
000000011000
> Total Liabilities 
0
155
204
272
207
874
449
1,328
932
1,178
2,562
5,145
5,1452,5621,1789321,3284498742072722041550
   > Total Current Liabilities 
0
155
204
266
195
690
416
1,273
885
1,078
2,447
4,850
4,8502,4471,0788851,2734166901952662041550
       Short-term Debt 
0
0
0
0
7
161
3
83
83
113
75
148
148751138383316170000
       Short Long Term Debt 
0
0
0
0
7
161
3
0
0
0
0
0
00000316170000
       Accounts payable 
0
152
197
22
19
255
125
124
159
487
481
949
94948148715912412525519221971520
       Other Current Liabilities 
0
2
7
27
169
435
291
1,149
726
591
1,965
3,901
3,9011,9655917261,14929143516927720
   > Long-term Liabilities 
0
0
0
7
12
184
32
54
46
100
115
295
295115100465432184127000
       Long term Debt Total 
0
0
0
0
0
161
0
0
0
14
0
103
10301400016100000
       Other Liabilities 
0
0
0
7
12
23
32
54
46
85
115
192
1921158546543223127000
> Total Stockholder Equity
32
0
-56
4,714
3,514
590
695
-406
2,313
20,504
10,061
-2,589
-2,58910,06120,5042,313-4066955903,5144,714-56032
   Retained Earnings -55,535-42,458-31,472-17,958-13,642-10,852-9,178-6,153-4,627-86200
   Accumulated Other Comprehensive Income 
0
0
0
2,959
2,248
1,533
1,516
1,663
1,805
8,678
8,551
8,835
8,8358,5518,6781,8051,6631,5161,5332,2482,959000
   Capital Surplus 000000000000
   Treasury Stock000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue4,431
Cost of Revenue-0
Gross Profit04,431
 
Operating Income (+$)
Gross Profit0
Operating Expense-17,243
Operating Income-12,905-17,243
 
Operating Expense (+$)
Research Development0
Selling General Administrative4,113
Selling And Marketing Expenses1,118
Operating Expense17,2435,231
 
Net Interest Income (+$)
Interest Income178
Interest Expense-173
Other Finance Cost-122
Net Interest Income-117
 
Pretax Income (+$)
Operating Income-12,905
Net Interest Income-117
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-13,077-17,187
EBIT - interestExpense = -13,077
-8,623
-12,905
Interest Expense173
Earnings Before Interest and Taxes (EBIT)-12,905-12,905
Earnings Before Interest and Taxes (EBITDA)-12,688
 
After tax Income (+$)
Income Before Tax-13,077
Tax Provision-0
Net Income From Continuing Ops-13,077-13,077
Net Income-13,077
Net Income Applicable To Common Shares-13,077
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses17,243
Total Other Income/Expenses Net4,282117
 

Technical Analysis of Recce
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Recce. The general trend of Recce is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Recce's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Recce Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.505 < 0.505 < 0.505.

The bearish price targets are: 0.46 > 0.435 > 0.435.

Tweet this
Recce Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Recce Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Recce Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Recce Ltd.

Recce Ltd Daily Moving Average Convergence/Divergence (MACD) ChartRecce Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Recce Ltd. The current adx is .

Recce Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Recce Ltd.

Recce Ltd Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Recce Ltd.

Recce Ltd Daily Relative Strength Index (RSI) ChartRecce Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Recce Ltd.

Recce Ltd Daily Stochastic Oscillator ChartRecce Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Recce Ltd.

Recce Ltd Daily Commodity Channel Index (CCI) ChartRecce Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Recce Ltd.

Recce Ltd Daily Chande Momentum Oscillator (CMO) ChartRecce Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Recce Ltd.

Recce Ltd Daily Williams %R ChartRecce Ltd Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Recce Ltd.

Recce Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Recce Ltd.

Recce Ltd Daily Average True Range (ATR) ChartRecce Ltd Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Recce Ltd.

Recce Ltd Daily On-Balance Volume (OBV) ChartRecce Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Recce Ltd.

Recce Ltd Daily Money Flow Index (MFI) ChartRecce Ltd Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Recce Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-10-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Recce Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Recce Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.470
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Recce with someone you think should read this too:
  • Are you bullish or bearish on Recce? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Recce? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Recce Ltd

I send you an email if I find something interesting about Recce Ltd.


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about Recce Ltd.

Receive notifications about Recce Ltd in your mailbox!